Responses

Download PDFPDF

Original research
Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Thrombocytopenia in COVID-19 patients

    Fumagalli et al. conducted a retrospective cohort study to develop a clinical risk score to predict the in-hospital mortality in COVID-19 patients ≥18 years [1]. Significant predictors of mortality were increasing age, number of chronic diseases, respiratory rate, decreasing PaO2/FiO2, serum creatinine and decreasing platelet count of mortality. I have come concerns about their study with special reference to thrombocytopenia in COVID-19 patients.

    There have been many meta-analyses of presenting severe health hazard of thrombocytopenia in COVID-19 patients. Three papers in British Journal of Haematology [2-4], two papers in European journal of Clinical Investigation [5,6], and one paper n Biomarker Research [7]. Although severe health hazards of thrombocytopenia in COVID-19 patients has been consistently reported by meta-analyses, a cohort study with minimum bias should also be conducted with special reference to comorbidity and aging.

    References
    1. Fumagalli C, Rozzini R, Vannini M, et al. Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study. BMJ Open. 2020 Sep 25;10(9):e040729.
    2. Zhou M, Qi J, Li X, et al. The proportion of patients with thrombocytopenia in three human-susceptible coronavirus infections: a systematic review and meta-analysis. Br J Haematol. 2020 May;189(3):438-441.
    3. Jiang SQ, Huang QF, Xie WM, et al. The association between severe COVID-19 and low platelet count: eviden...

    Show More
    Conflict of Interest:
    None declared.